118 related articles for article (PubMed ID: 20571277)
1. RCAS-1 serum and tumor levels in head and neck squamous cell carcinoma.
Brunner M; Erovic B; Heiduschka G; Schneider S; Pammer J; Frantal S; Thurnher D
Eur Surg Res; 2010; 44(3-4):214-9. PubMed ID: 20571277
[TBL] [Abstract][Full Text] [Related]
2. Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma.
Alhamarneh O; Agada F; Madden L; Stafford N; Greenman J
Head Neck; 2011 Mar; 33(3):415-23. PubMed ID: 20645289
[TBL] [Abstract][Full Text] [Related]
3. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
5. Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma.
Deng YF; Chen P; Lin YZ; Le JZ; Wu XL; Yu MQ; Zhuang PY; Gao MH
J Laryngol Otol; 2003 Mar; 117(3):190-4. PubMed ID: 12648374
[TBL] [Abstract][Full Text] [Related]
6. Plasma osteopontin is an independent prognostic marker for head and neck cancers.
Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT
J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC.
Molina R; Torres MD; Moragas M; Filella X; Jo J; Giménez N; Traserra J; Ballesta AM
Anticancer Res; 1995; 15(2):479-84. PubMed ID: 7763026
[TBL] [Abstract][Full Text] [Related]
8. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
[TBL] [Abstract][Full Text] [Related]
9. [Effect of tissue inhibitors of metalloproteinases (TIMP) on course and prognosis of head and neck squamous cell carcinoma].
Klisho EV; Kondakova IV; Choĭnzonov EL; Shishkin DA; Cheremisina OV; Chuzhevskaia SIu
Vopr Onkol; 2009; 55(6):717-21. PubMed ID: 20210014
[TBL] [Abstract][Full Text] [Related]
10. EB-D fibronectin expression in squamous cell carcinoma of the head and neck.
Mhawech P; Dulguerov P; Assaly M; Ares C; Allal AS
Oral Oncol; 2005 Jan; 41(1):82-8. PubMed ID: 15598590
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
[TBL] [Abstract][Full Text] [Related]
12. [Study of Cyfra 21-1 as a new tumor marker for the diagnosis of epidermoid carcinoma of the head and neck].
González Sánchez E; López-Ríos Velasco J; Calvo Boizas E; García-Talavera Fernández JR; Martín Ro-dríguez M; Muñoz Herrera A; Del Cañizo Alvarez A
Acta Otorrinolaringol Esp; 1999 Mar; 50(2):85-9. PubMed ID: 10217679
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of folate, homocysteine, and vitamin B12 in head and neck squamous cell carcinoma and in laryngeal leukoplakia.
Almadori G; Bussu F; Galli J; Cadoni G; Zappacosta B; Persichilli S; Minucci A; Giardina B; Maurizi M
Cancer; 2005 Jan; 103(2):284-92. PubMed ID: 15593092
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance.
Liu Y; Xie C; Zhang X; Huang D; Zhou X; Tan P; Qi L; Hu G; Tian Y; Qiu Y
Eur J Cancer; 2010 Nov; 46(16):3007-15. PubMed ID: 20724142
[TBL] [Abstract][Full Text] [Related]
15. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.
Kim CH; Lee JS; Kang SO; Bae JH; Hong SP; Kahng H
Oral Oncol; 2007 Nov; 43(10):1021-5. PubMed ID: 17306605
[TBL] [Abstract][Full Text] [Related]
16. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients.
Brunner M; Thurnher D; Heiduschka G; Grasl MCh; Brostjan C; Erovic BM
J Surg Oncol; 2008 Dec; 98(7):545-50. PubMed ID: 18792958
[TBL] [Abstract][Full Text] [Related]
18. Head and neck squamous cell carcinoma: measurement of plasma parathyroid hormone-related protein and serum and urine calcium concentrations.
Sellers RS; Schuller DE; Sharma PK; Tannehill-Gregg SH; Capen CC; Rosol TJ
Otolaryngol Head Neck Surg; 2000 Nov; 123(5):558-62. PubMed ID: 11077340
[TBL] [Abstract][Full Text] [Related]
19. [Role of the tumor marker TAG-72 in head and neck neoplasms].
Altissimi G; von Garrel C
HNO; 1990 Oct; 38(10):364-6. PubMed ID: 2283330
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]